238 related articles for article (PubMed ID: 4480360)
1. [Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia].
Sterner W; Schultz A
Arzneimittelforschung; 1974 Dec; 24(12):1990-2. PubMed ID: 4480360
[No Abstract] [Full Text] [Related]
2. [Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia].
Bucalossi A; Buzzelli G; D'Alessandro A
Clin Ter; 1979 Apr; 89(2):127-49. PubMed ID: 226307
[No Abstract] [Full Text] [Related]
3. [New drug combination for medical management of hyperlipemia: clinical study].
Fischer M; Falkensammer C
Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):585-9. PubMed ID: 340391
[TBL] [Abstract][Full Text] [Related]
4. [Etofibrate and clofibrate in a double-blind trial on patients with raised serum-lipid levels (author's transl)].
Kaffarnik H; Schneider J; Haase W
Dtsch Med Wochenschr; 1975 Nov; 100(48):2486-8. PubMed ID: 1104303
[TBL] [Abstract][Full Text] [Related]
5. [Serum lipid-lowering drugs following myocardial infarction].
Schettler G
Dtsch Med Wochenschr; 1975 Aug; 100(31):1611-2. PubMed ID: 168052
[No Abstract] [Full Text] [Related]
6. [The problem of an antilipemic synergism between the action of nicotinic acid and the sulphated polyanion SP54 (author's transl)].
Levy H
Med Klin; 1974 Sep; 69(36):1441-7. PubMed ID: 4280008
[No Abstract] [Full Text] [Related]
7. [Field study on the decrease of lipids using etofibrate].
Schneider J; Haase W; Kaffarnik H
Fortschr Med; 1976 May; 94(13):785-90. PubMed ID: 8362
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological treatment of primary hyperlipoproteinemia].
Ciświcka-Sznajderman M
Pol Tyg Lek; 1976 Feb; 31(7):289-91. PubMed ID: 768941
[No Abstract] [Full Text] [Related]
9. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].
Maroto ML; Priego JG; Piña M; Catalán RE
Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396
[No Abstract] [Full Text] [Related]
10. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
Dimroth H
Med Klin; 1979 Jun; 74(22):875-6. PubMed ID: 470785
[TBL] [Abstract][Full Text] [Related]
11. [The efficacy of substances with antihypoxic action in experimental hyperlipidemia].
Ryzhenkov VE; Remezova OV; Triufanov VF; Vasil'eva LE
Eksp Klin Farmakol; 1992; 55(5):39-41. PubMed ID: 1305449
[TBL] [Abstract][Full Text] [Related]
12. [Bezafibrate and delayed action etofibrate in hyperlipidemia].
Lang PD; Vollmar J
Dtsch Med Wochenschr; 1983 Feb; 108(8):302-5. PubMed ID: 6825604
[No Abstract] [Full Text] [Related]
13. [Diet and drug therapy of hyperlipoproteinemia].
Sirtori C
Minerva Med; 1975 Nov; 66(79):4184-5. PubMed ID: 1196507
[No Abstract] [Full Text] [Related]
14. [Evaluation of the antilipaemic potential of etofylline clofibrate, its metabolites and clofibrate in dietary-induced hyperlipidaemia in the rat (author's transl)].
Sterner W; Chibanguza G; Metz G
Arzneimittelforschung; 1980; 30(11b):2038-41. PubMed ID: 7194056
[TBL] [Abstract][Full Text] [Related]
15. Nutritional properties of a fraction separated from heated safflower oil.
Ahlström A; Järvinen R; Packalén L; Mäkinen E
Med Biol; 1974 Oct; 52(5):343-9. PubMed ID: 4427466
[No Abstract] [Full Text] [Related]
16. Efficacy and interactions of oxandrolone, halo-fenate and clofibrate in a factorial study on experimental acute nephrotic hyperlipidemia.
Schapel GJ; Edwards KD
J Pharmacol Exp Ther; 1975 Jul; 194(1):274-84. PubMed ID: 1171221
[TBL] [Abstract][Full Text] [Related]
17. Hyperlipidemia: reducing the chances of cardiovascular disease.
Nash DT
Geriatrics; 1984 Jul; 39(7):99-100, 103-4,108-9 passim. PubMed ID: 6588017
[No Abstract] [Full Text] [Related]
18. Hypolipemic activity of clofibrate-related compounds. 2nd Communication.
Metz G; Specker M
Arzneimittelforschung; 1977 Jul; 27(7):1421-4. PubMed ID: 578466
[TBL] [Abstract][Full Text] [Related]
19. The hypolipidaemic effect of gemfibrozil (CI-719) in laboratory animals.
Rodney G; Uhlendorf P; Maxwell RE
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):6-10. PubMed ID: 828263
[No Abstract] [Full Text] [Related]
20. [Hypolipidemic activity of glycine and its derivatives].
Ryzhenkov VE; Molokovskiĭ DS; Ioffe DV
Vopr Med Khim; 1984; 30(2):78-80. PubMed ID: 6740998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
